Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis-Reference-Cited by-同舟云学术

Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis

Published:2021-09 Issue:3 Volume:75 Page:589-599
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Villanueva Càndid^ORCID,Albillos Agustín,Genescà Joan,Garcia-Pagan Joan C.,Brujats Anna^ORCID,Calleja José L.,Aracil Carles,Bañares Rafael,Morillas Rosa M.^ORCID,Poca María,Peñas Beatriz,Augustin Salvador,Abraldes Juan G.,Alvarado Edilmar^ORCID,Torres Ferran^ORCID,Bosch Jaume

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Liver cirrhosis;Tsochatzis;Lancet,2014

2. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies;D’Amico;J Hepatol,2006

3. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis;Ripoll;Gastroenterology,2007

4. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management: 2016 practice guidance by the American Association for the Study of Liver Diseases;Garcia-Tsao;Hepatology,2017

5. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort);Trinchet;Hepatology,2015

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study;Alimentary Pharmacology & Therapeutics;2024-08

2. Infectious Complications of Portal Hypertension;Clinics in Liver Disease;2024-08

3. Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease;International Journal of Molecular Sciences;2024-07-30

4. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease;JHEP Reports;2024-04

5. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01